NYSEAMERICAN:CCEL Cryo-Cell International (CCEL) Stock Price, News & Analysis $4.70 -0.05 (-1.05%) Closing price 08/29/2025 04:10 PM EasternExtended Trading$4.72 +0.02 (+0.43%) As of 08/29/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock About Cryo-Cell International Stock (NYSEAMERICAN:CCEL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get CCEL alerts:Sign Up Key Stats Today's Range$4.67▼$4.7750-Day Range$4.11▼$5.4352-Week Range$4.09▼$9.43Volume9,485 shsAverage Volume17,126 shsMarket Capitalization$37.88 millionP/E RatioN/ADividend Yield12.77%Price Target$8.50Consensus RatingBuy Company Overview Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida. Read More Cryo-Cell International Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks70th Percentile Overall ScoreCCEL MarketRank™: Cryo-Cell International scored higher than 70% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingCryo-Cell International has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageCryo-Cell International has received no research coverage in the past 90 days.Read more about Cryo-Cell International's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Cryo-Cell International is -156.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cryo-Cell International is -156.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.28% of the float of Cryo-Cell International has been sold short.Short Interest Ratio / Days to CoverCryo-Cell International has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cryo-Cell International has recently increased by 34.15%, indicating that investor sentiment is decreasing significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend LeadershipCryo-Cell International is a leading dividend payer. It pays a dividend yield of 12.77%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthCryo-Cell International does not have a long track record of dividend growth.Read more about Cryo-Cell International's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.28% of the float of Cryo-Cell International has been sold short.Short Interest Ratio / Days to CoverCryo-Cell International has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cryo-Cell International has recently increased by 34.15%, indicating that investor sentiment is decreasing significantly. News and Social Media3.7 / 5News Sentiment1.73 News SentimentCryo-Cell International has a news sentiment score of 1.73. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.09 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Cryo-Cell International this week, compared to 0 articles on an average week.MarketBeat Follows1 people have added Cryo-Cell International to their MarketBeat watchlist in the last 30 days. Company Ownership3.3 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Cryo-Cell International insiders have bought more of their company's stock than they have sold. Specifically, they have bought $285,561.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders36.86% of the stock of Cryo-Cell International is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 10.44% of the stock of Cryo-Cell International is held by institutions.Read more about Cryo-Cell International's insider trading history. Receive CCEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cryo-Cell International and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CCEL Stock News HeadlinesDavid Portnoy Buys 11,101 Shares of Cryo-Cell International (NYSEAMERICAN:CCEL) StockAugust 28 at 8:57 AM | insidertrades.comDavid Portnoy Buys 9,089 Shares of Cryo-Cell International (NYSEAMERICAN:CCEL) StockAugust 20, 2025 | insidertrades.comThis stock could leave NVDA in the dustInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast. | InvestorPlace (Ad)Insider Buying: Cryo-Cell International Inc. (NYSEAMERICAN:CCEL) CEO Buys 5,826 Shares of StockAugust 19, 2025 | insidertrades.comCryo-Cell International, Inc. Provides Dividend UpdateAugust 14, 2025 | finance.yahoo.comCCEL | Cryo-Cell International Inc. - The Wall Street JournalJuly 16, 2025 | wsj.comCord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2025 Financial ResultsJuly 15, 2025 | businesswire.comCCEL Cryo-Cell International, Inc. - Seeking AlphaJune 27, 2025 | seekingalpha.comSee More Headlines CCEL Stock Analysis - Frequently Asked Questions How have CCEL shares performed this year? Cryo-Cell International's stock was trading at $6.50 at the beginning of the year. Since then, CCEL shares have decreased by 27.7% and is now trading at $4.70. How were Cryo-Cell International's earnings last quarter? Cryo-Cell International Inc. (NYSEAMERICAN:CCEL) released its quarterly earnings data on Tuesday, October, 15th. The company reported $0.13 EPS for the quarter, topping analysts' consensus estimates of $0.02 by $0.11. The business earned $8.07 million during the quarter. Cryo-Cell International had a negative trailing twelve-month return on equity of 1.07% and a negative net margin of 0.53%. Who are Cryo-Cell International's major shareholders? Cryo-Cell International's top institutional shareholders include Topline Capital Management LLC (0.50%). View institutional ownership trends. How do I buy shares of Cryo-Cell International? Shares of CCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cryo-Cell International own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cryo-Cell International investors own include Meta Platforms (META), Alimera Sciences (ALIM), Crescent Biopharma (CBIO), iClick Interactive Asia Group (ICLK), NVIDIA (NVDA), AcelRx Pharmaceuticals (ACRX) and Aspen Group (ASPU). Company Calendar Last Earnings10/15/2024Today8/31/2025Fiscal Year End11/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Medical Services Sub-IndustryHealthcare Current SymbolNYSEAMERICAN:CCEL CIK862692 Webwww.cryo-cell.com Phone(813) 749-2100Fax813-855-4745Employees90Year Founded1989Price Target and Rating Average Price Target for Cryo-Cell International$8.50 High Price Target$8.50 Low Price Target$8.50 Potential Upside/Downside+80.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)($1.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$400 thousand Net Margins-0.53% Pretax Margin5.15% Return on Equity-1.07% Return on Assets-0.27% Debt Debt-to-Equity RatioN/A Current Ratio0.60 Quick Ratio0.57 Sales & Book Value Annual Sales$31.99 million Price / Sales1.18 Cash Flow$0.18 per share Price / Cash Flow26.22 Book Value($1.64) per share Price / Book-2.87Miscellaneous Outstanding Shares8,060,000Free Float5,087,000Market Cap$37.88 million OptionableNot Optionable Beta0.64 Social Links 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NYSEAMERICAN:CCEL) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cryo-Cell International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cryo-Cell International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.